QL
LXRX icon

Quarry LP’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quarry LP’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
156,186
+46,186
+42% +$90K 0.03% 202
2026
Q1 		$172K Buy
110,000
+22,000
+25% +$32K 0.03% 364
2025
Q4 		$101K Buy
+88,000
New +$121K 0.02% 442

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quarry LP's LXRX Position: Q2 2026 in Review

Quarry LP increased its Lexicon Pharmaceuticals (LXRX) stake by 42% in Q2 2026, buying an estimated $90K and bringing the position to 156,186 shares worth $375K. The position accounts for 0.03% of the portfolio, ranked #202.

Quarry LP first reported a position in LXRX in Q4 2025 and has held it in 3 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Quarry LP held 156,186 shares of Lexicon Pharmaceuticals worth $375K as of Q2 2026.
  • Quarry LP bought 46,186 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $90K.
  • Lexicon Pharmaceuticals made up 0.03% of Quarry LP's portfolio in Q2 2026, its #202 holding.
  • Quarry LP first reported a position in Lexicon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.